By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Pacific Biosciences has been added to the Nasdaq Biotechnology Index.

Nasdaq's semi-annual re-ranking has resulted in six firms being added to the Biotech Index, though PacBio is the only life science tools firm among the new members. The new Index is effective prior to market open on Monday, May 23.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Lawmakers have asked four direct-to-consumer genetic testing companies to explain their privacy policies and security measures, according to Stat News.

The Trump Administration has proposed a plan to reorganize the federal government, the Washington Post reports.

In Science this week: genetic overlap among many psychiatric disorders, and more.

The Economist writes that an increasing number of scientific journals don't do peer review.